Funding for this research was provided by:
Emerging Infectious and Major Disease Research Program (AS-KPQ-110-EIMD)
Ministry of Science and Technology, Taiwan (MOST- 108-3114-Y-001-002, MOST-108-2823-8-001-001, MOST 109-3114-Y- 001-001)
Received: 25 September 2021
Accepted: 12 November 2021
First Online: 23 November 2021
: All animal experiments were performed according to established guidelines for the ethical use and care of animals provided by the Institutional Animal Care and Use Committee (IACUC) at Academia Sinica, Taiwan. All experiments involving animals were approved by the IACUC (protocol 20-05-147).
: Not applicable.
: Related to this work, the Institute of Cellular and Organismic Biology, Academia Sinica have filed a patent application on which HCW, YLL and MHT are named as inventors. The other authors declare no conflict of interest. A collaborative research agreement with United BioPharma Inc. (July 1, 2021-February 28, 2022) provided research funding of US$35,790 (NT$1,000,000) to Academia Sinica.